In addition, Franke et al. [47] reported that SASH1 deficiency in colon cancer cells increased in vivo tumor formation at the primary site and the number of metastatic lesions, the latter being blocked by CRISPR/Cas9-based CrkL deficiency. The gene discussed is CRKL; the disease is malignant colon neoplasm.